NRXN3 Gene Curation
- Katherine Lafferty
Gene-disease assertions not curated here (add link or write note):
Disease | Autism |
|---|---|
Inheritance | Autosomal dominant |
Prevalence |
Source: |
Rapid or full curation? | Rapid Full |
GenCC- Ambry: Limited (AD Autism) SFARI- Category 1(High Confidence) for ASD | |
Clinical Validity Scoring Notes and points | Variant/Case Evidence: PMID: 22209245- Deletions described in 4 families. However, two are inherited from apparently unaffected family members while one is de novo and the 4th is inherited from a more mildly affected parent. If you don’t count those inherited (1pt + 1.5 pts = 2.5 pts)
 PMID: 35813072- p.R176* in individual with ASD, inherited from both with mild ID and speech/language delay (1 pt) Segregation Evidence: Case/Control Evidence: Experimental Evidence: Source: |
Clinical Validity Points Total |
Source: |
Clinical Validity Classification Definitive (12pts) Strong (12pts) Moderate (7-11pts) Limited (0.1-6pts) No genetic evidence Refuted Disputed | LIMITED Source: |
Molecular Mechanism Loss of function Gain of function Dominant negative Unknown Other | Loss of function / Gain of function / Dominant Negative
|
Penetrance Complete (100%) High (≥80%) Moderate (<80% and >20%) Low (≤20%) (list source/PMID) |
Source: |
Age of Onset Congenital Pediatric Adolescent Adulthood Late adulthood (list source/PMID) |
|
Severity |
|
Clinical Features |
Sources: |
HPO Terms |
|
Gene SOPs & Notes | LINK if SOP is a long document. Short notes if it is easy to digest. eg. Last known truncating variant |
Curation Summary |
|
Case ID, Curator name, Date, Jira ticket link |
|